ReviewCancers2026

Zipalertinib-A Novel Treatment Opportunity for Non-Small Cell Lung Cancers with Exon 20 Insertions and Uncommon EGFR Mutations.

Wolfram C M Dempke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.